Factors Associated with the Development of Anti-drug Antibodies to TNFi and the Consequences for Axial Spondyloarthritis: A Two-year Follow-up Study

Objective: To evaluate the development of anti-drug antibodies (ADAb) against tumor necrosis factor inhibitors (TNFi) therapy during a 2-year period and search the factors linked to patients with axial spondyloarthritis (axSpA). Methods: Biologic-naive patients with axSpA were included in this ob...

Full description

Bibliographic Details
Published in:European Journal of Rheumatology
Main Authors: Elif Durak Ediboğlu, Muhammed Çınar, Didem Kozacı, Dilek Solmaz, Gökhan Sargın, Ömer Karadağ, Gülay Kınıklı, Umut Kalyoncu, Sedat Yılmaz, Taşkın Şentürk, Gökhan Kabadayı, Gökhan Keser, Gülen Hatemi, Kübra Kaya, Mustafa Özmen, Figen Yargucu, Yeşim Özgüler, Ayşe Cefle, Önay Gerçik, Bünyamin Kısacık, Servet Akar
Format: Article
Language:English
Published: Ahmet Mesut Onat 2024-07-01
Online Access:https://www.eurjrheumatol.org/en/factors-associated-with-the-development-of-anti-drug-antibodies-to-tnfi-and-the-consequences-for-axial-spondyloarthritis-a-two-year-follow-up-study-133542

Similar Items

Similar Items